The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Concise Review: Tissue-Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future
Open accessAbstract
In surgical repair for heart or vascular disease, it is often necessary to implant conduits or correct tissue defects. The most commonly used graft materials to date are (a) artificial grafts; (b) autologous tissues, such as pericardium and saphenous vein; (c) allografts; and (d) xenografts. However, none of these four options offer growth potential, and all are associated with varying levels of thrombogenicity and susceptibility to infection. The lack of growth potential of these four options is particularly important in pediatric cardiac surgery, where patients will often outgrow their vascular grafts and require additional operations. Thus, developing a material with sufficient durability and growth potential that will function as the child grows older will eliminate the need for reoperation and significantly reduce morbidity and mortality of some types of congenital heart defects. Vascular tissue engineering is a relatively new field that has undergone enormous growth over the last decade. The goal of vascular tissue engineering is to produce neovessels and neo-organ tissue from autologous cells using a biodegradable polymer as a scaffold. The most important advantage of tissue-engineered implants is that these tissues can grow, remodel, rebuild, and respond to injury. Once the seeded autologous cells have deposited an extracellular matrix and the original scaffold is biodegraded, the tissue resembles and behaves as native tissue. When tissue-engineered vascular grafts are eventually put to use in the clinical arena, the quality of life in patients after surgery will be drastically improved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-Dimensional Cell Culture Matrices: State of the Art
Lee, J., Cuddihy, M. J., & Kotov, N. A. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/teb.2007.0150 · Cited by 1,047
Cited by
Small-diameter vascular tissue engineering
Seifu, D. G., Purnama, A., Mequanint, K., & Mantovani, D. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.77 · Cited by 501
Flexible shape-memory scaffold for minimally invasive delivery of functional tissues
Montgomery, M., Ahadian, S., Davenport Huyer, L., Lo Rito, M., Civitarese, R. A., Vanderlaan, R. D., Wu, J., Reis, L. A., Momen, A., Akbari, S., et al. (2017) · Nature Materials · doi:10.1038/nmat4956 · Cited by 409
Emerging chitin and chitosan nanofibrous materials for biomedical applications
Ding, F., Deng, H., Du, Y., Shi, X., & Wang, Q. (2014) · Nanoscale · doi:10.1039/c4nr02814g · Cited by 342
Shafiq, M., & Kim, S. H. (2016) · Macromolecular Research · doi:10.1007/s13233-016-4138-x · Cited by 20
Rhee, J., Shafiq, M., Kim, D., Jung, Y., & Kim, S. H. (2019) · Macromolecular Research · doi:10.1007/s13233-019-7003-x · Cited by 9
Metadata
- Authors
- Kurobe, H., Maxfield, M. W., Breuer, C. K., & Shinoka, T.
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-28
- Volume
- 1
- Issue
- 7
- Pages
- 566-571
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- OpenAlex
- W2120608193
- Cited by
- 162
- References
- 1
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concise Review: Tissue-Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future. https://app.cochat.ai/papers/10.5966/sctm.2012-0044
- The paper
- Kurobe, H., Maxfield, M. W., Breuer, C. K., & Shinoka, T. (2012). Concise Review: Tissue-Engineered Vascular Grafts for Cardiac Surgery: Past, Present, and Future. Stem Cells Translational Medicine. https://doi.org/10.5966/sctm.2012-0044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.